Manchester Dysmorphology and Developmental Disorders Conferences

Introduction

The Manchester Dysmorphology Conference (MDC) is a biennial event that has brought together global experts in genomic syndromology since 1984. Established by Professor Dian Donnai, MDC promotes the exchange of knowledge and ideas to advance the understanding of developmental disorders and congenital malformations. Each conference offers leading-edge content and a supportive setting, encouraging discussions, building collaborations, and inspiring innovative strategies to improve the lives of individuals living with rare conditions.

Purpose

Cutting-Edge Content: Stay at the forefront of research in developmental disorders, congenital malformations, and rare conditions.
Global Collaboration: Network with an international community of clinicians, geneticists, researchers, and healthcare professionals.
Patient-Centered Impact: Translate new discoveries into real-world applications that enhance patient well-being and support.
Welcoming Environment: Experience an atmosphere designed to encourage conversation, collaboration, and the sharing of transformative ideas

Past Conferences and Archives

Below is a curated look at the history of the Manchester Dysmorphology Conference, featuring the full programmes of each previous event:

20th Manchester Dysmorphology and Developmental Disorders Conference 16th-19th Nov 2025

19th Manchester Dysmorphology Conference – October 2023

Highlights from the 2025 Manchester Dysmorphology and Developmental Disorders Conferences (MDC20)

Held 16–18 November 2025 at the Manchester Deansgate Hotel, MDC20 brought together 270 genomics experts from 38 countries.
71 presentations showcased the latest advances in the science, diagnosis, and treatment of rare conditions.
Collaborative Spirit: A friendly, open atmosphere encouraged in-depth discussion, sparked new collaborations, and inspired innovative solutions for patient care.
Worldwide Impact: The conference underscored the importance of global cooperation in driving progress in genomics and dysmorphology research.